On September 28, 2020, Principia Biopharma Inc. announced that, Pursuant to the Merger Agreement, on August 28, 2020, the Sanofi commenced a tender offer to acquire all of the outstanding shares of common stock of the Company, $0.0001 par value per share at a purchase price of $100.00 per Share in cash. Further, the Company stated that, Merger took under Delaware law without a vote of the Company’s stockholders. In addition, on September 28, 2020, the Company notified the Nasdaq Global Select Market of the consummation of the Merger and requested to suspend trading of the Shares.